Abstract:Background: The most refractory symptom of herpes zoster (HZ) is pain. Approximately 90% of people who have HZ suffer from pain. Early use of antiviral medications has been found to reduce pain across all stages of the disease. Although many antiviral agents via oral or intravenous administration were recommended by clinical practice, the best approach to prevent HZ-associated pain remains uncertain. Objectives: The purpose of this study was to compare the efficacy and adverse events of various antiviral agents used for the treatment of HZ-associated pain through a network meta-analysis. Study design: A systematic review and meta-analysis. Setting: The Cochrane Register of Controlled Trials, Embase, and PubMed were searched from inception to Feb 2020. Methods: Randomized clinical trials evaluating antiviral agents currently available for treating HZ-associated pain were included. We extracted data in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and conducted network meta-analyses with random-effects models. The primary outcome was the presence of acute pain at the end of anti-virus treatment, and the secondary outcomes included the presence of pain at 28-30 days after the onset of the acute herpetic rash, the presence of postherpetic neuralgia (PHN), and any other adverse events. Results: A total of 17 randomized control trials with 5,579 participants were included in this study. According to the results of the network meta-analysis, for the treatment of acute pain, there was no significant difference between oral acyclovir and intravenous acyclovir. Furthermore, oral famciclovir was the most effective treatment concerning both the odds ratio (OR) (superior to placebo OR = 0.25; 95% CI: 0.13~0.48) and the surface under the cumulative ranking curve (SUCRA) values of 0.84 for the treatment of acute pain among all the oral antiviral agents. For the presence of pain at 28-30 days, no significant difference was observed in efficacy between all antiviral treatments and placebo concerning the OR; however, oral valaciclovir ranked first (SUCRA values of 0.96). For the presence of NPH, oral famciclovir was determined to be the most effective (SUCRA values of 0.77) treatment with an efficacy of 0.42 (95% CI: 0.18~0.99) versus placebo. For adverse events, there was no significant difference between oral antivirals and placebo; however, intravenous acyclovir ranked last with a score of OR 4.31 (95% CI: 1.26~14.75) versus placebo. Limitations: The distribution of severity of pain was different in various studies; then, the lack of availability of individual data prevented us from analyzing the effects of the risk factors. Conclusions: For the treatment of acute pain and PHN, oral famciclovir was the most effective treatment among all the oral antiviral agents. For alleviating pain after 28-30 days, oral valaciclovir appeared to be the most effective among all antiviral agents. Additionally, all oral antiviral agents were well tolerated. Clinical trial registration information: PROSPERO under the identification CRD42020212834.

Clinical Evaluation of Ganciclovir and Aciclovirin Treatment on Herpes Zoster

The Clinical Efficacy of Oral Valaciclovir Plus Intradermal Injection of Steroid Hormone for the Treatment of Herpes Zoster Patients

[Clinical Assessment of Oral Ganciclovir Capsules on the Treatment of Herpes Simplex Keratitis].

[Efficacy and safety of different doses of antiviral agents in the treatment of herpes zoster: a meta-analysis]

Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain.

Associations between Different Antivirals and Hospital acquired Acute Kidney Injury in Adults with Herpes Zoster

Systematic reviews of ganciclovir combined with traditional Chinese medicine for herpes simplex keratitis

A Network Meta-Analysis of Randomized Clinical Trials to Assess the Efficacy and Safety of Antiviral Agents for Immunocompetent Patients with Herpes Zoster-Associated Pain

Efficacy and Safety of Gabapentinoids for Acute Herpes Zoster Neuralgia

Acyclovir with and without Prednisone for the Treatment of Herpes Zoster

Application of Ozone in the Treatment of Herpes Zoster

Clinical efficacy of LED golden light combined with acyclovir in the treatment of herpes zoster: a single-center prospective study

Comparison of efficacy of acupuncture-related therapy in the treatment of herpes zoster: A network meta-analysis of randomized controlled trials

Clinical Study on the Effect of Safflower Gualou-Gancao Decoction Combined with Pulsed Radio Frequency for the Patients with Herpes Zoster

Evaluation of efficacy and safety of brivudine once daily versus 4 times daily in the treatment of herpes zoster

Effect of antivirals plus low-dose, short-term glucocorticoids on post-herpetic neuralgia

Discourse on intraocular injection of ganciclovir treatment for retinitis

Comparing Prodrugs with Acyclovir for Treating Postherpetic Neuralgia among Herpes Zoster Patients: A Systematic Review and Meta-Analysis

Effectiveness of oral ganciclovir on prevention of cytomegalovirus infection after liver transplantation

A Randomized Controlled Multicenter Clinical Trial on Theefficacy and Safety of Recombinant Interferon Α-2A(yeast) Injection in Treatment of Herpes Zoster